FR2978160B1 - PREPARATION AND USE OF MERISTEMATIC CELLS OF THE DENDROBIUM AND PHALAENOPSIS GENES WITH HIGH PHENYLPROPANOID CONTENT, WATER-SOLUBLE POLYSACCHARIDES AND EXTENSINS - Google Patents

PREPARATION AND USE OF MERISTEMATIC CELLS OF THE DENDROBIUM AND PHALAENOPSIS GENES WITH HIGH PHENYLPROPANOID CONTENT, WATER-SOLUBLE POLYSACCHARIDES AND EXTENSINS

Info

Publication number
FR2978160B1
FR2978160B1 FR1102301A FR1102301A FR2978160B1 FR 2978160 B1 FR2978160 B1 FR 2978160B1 FR 1102301 A FR1102301 A FR 1102301A FR 1102301 A FR1102301 A FR 1102301A FR 2978160 B1 FR2978160 B1 FR 2978160B1
Authority
FR
France
Prior art keywords
cell culture
meristematic cells
phalaenopsis
preparation
extensins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1102301A
Other languages
French (fr)
Other versions
FR2978160A1 (en
Inventor
Giovanna Pressi
Toso Roberto Dal
Elena Sgaravatti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IRB Istituto di Ricerche Biotecnologiche SpA
Original Assignee
IRB Istituto di Ricerche Biotecnologiche SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IRB Istituto di Ricerche Biotecnologiche SpA filed Critical IRB Istituto di Ricerche Biotecnologiche SpA
Priority to FR1102301A priority Critical patent/FR2978160B1/en
Priority to FR1160848A priority patent/FR2978161B1/en
Publication of FR2978160A1 publication Critical patent/FR2978160A1/en
Application granted granted Critical
Publication of FR2978160B1 publication Critical patent/FR2978160B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/898—Orchidaceae (Orchid family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/898—Orchidaceae (Orchid family)
    • A61K36/8984—Dendrobium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Cell culture obtained from meristematic cells of Dendrobiumplant and Phalaenopsisplant, comprises phenylpropanoid (greater than 0.1 wt.%) and hydrosoluble polysaccharides (greater than wt.%). An independent claim is included for the meristematic cells preparation comprising the cell culture and glycerol, where the cell culture is free from the liquid culture medium and has a weight/volume ratio of 5:95-50:50, preferably 20:50. ACTIVITY : Anabolic; Antiinflammatory; Dermatological; Gastrointestinal-Gen.; Antimicrobial; Respiratory-Gen.; Ophthalmological; Immunosuppressive. MECHANISM OF ACTION : Hyaluronidase inhibitor; Collagenase inhibitor. The hyaluronidase inhibiting activity of the cell culture (comprising Phalaenopsis aphrodite(800 mu g/ml)) was tested in extracellular matrix. The result showed that percentage inhibition rate of the cell culture was 87.5.
FR1102301A 2011-07-22 2011-07-22 PREPARATION AND USE OF MERISTEMATIC CELLS OF THE DENDROBIUM AND PHALAENOPSIS GENES WITH HIGH PHENYLPROPANOID CONTENT, WATER-SOLUBLE POLYSACCHARIDES AND EXTENSINS Active FR2978160B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR1102301A FR2978160B1 (en) 2011-07-22 2011-07-22 PREPARATION AND USE OF MERISTEMATIC CELLS OF THE DENDROBIUM AND PHALAENOPSIS GENES WITH HIGH PHENYLPROPANOID CONTENT, WATER-SOLUBLE POLYSACCHARIDES AND EXTENSINS
FR1160848A FR2978161B1 (en) 2011-07-22 2011-11-28 PREPARATION AND USE OF MERISTEMATIC CELLS BELONGING TO THE GENES DENDROBIUM, PHALAENOPSIS, ANISELLIA, POLYRRHIZA, VANILLA, CATTLEYA AND VANDA, OF HIGH PHENYLPROPANOID CONTENT, WATER-SOLUBLE POLYSACCHARIDES AND EXTENSINS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1102301A FR2978160B1 (en) 2011-07-22 2011-07-22 PREPARATION AND USE OF MERISTEMATIC CELLS OF THE DENDROBIUM AND PHALAENOPSIS GENES WITH HIGH PHENYLPROPANOID CONTENT, WATER-SOLUBLE POLYSACCHARIDES AND EXTENSINS

Publications (2)

Publication Number Publication Date
FR2978160A1 FR2978160A1 (en) 2013-01-25
FR2978160B1 true FR2978160B1 (en) 2013-08-16

Family

ID=45888360

Family Applications (2)

Application Number Title Priority Date Filing Date
FR1102301A Active FR2978160B1 (en) 2011-07-22 2011-07-22 PREPARATION AND USE OF MERISTEMATIC CELLS OF THE DENDROBIUM AND PHALAENOPSIS GENES WITH HIGH PHENYLPROPANOID CONTENT, WATER-SOLUBLE POLYSACCHARIDES AND EXTENSINS
FR1160848A Active FR2978161B1 (en) 2011-07-22 2011-11-28 PREPARATION AND USE OF MERISTEMATIC CELLS BELONGING TO THE GENES DENDROBIUM, PHALAENOPSIS, ANISELLIA, POLYRRHIZA, VANILLA, CATTLEYA AND VANDA, OF HIGH PHENYLPROPANOID CONTENT, WATER-SOLUBLE POLYSACCHARIDES AND EXTENSINS

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR1160848A Active FR2978161B1 (en) 2011-07-22 2011-11-28 PREPARATION AND USE OF MERISTEMATIC CELLS BELONGING TO THE GENES DENDROBIUM, PHALAENOPSIS, ANISELLIA, POLYRRHIZA, VANILLA, CATTLEYA AND VANDA, OF HIGH PHENYLPROPANOID CONTENT, WATER-SOLUBLE POLYSACCHARIDES AND EXTENSINS

Country Status (1)

Country Link
FR (2) FR2978160B1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140087026A1 (en) * 2012-09-26 2014-03-27 Dianaplantsciences, S.A.S. Novel food composition of whole plant cells
CN103202233B (en) * 2013-04-28 2014-06-11 安徽农业大学 Butterfly orchid anti-browning tissue culture method and anti-browning culture medium
CN104195098A (en) * 2014-09-22 2014-12-10 古焕庆 Dendrobium officinale stem cell and isolated culture method thereof
CN104686362A (en) * 2015-03-24 2015-06-10 芜湖东源新农村开发股份有限公司 Butterfly orchid tissue culturing method
CN105495570B (en) * 2015-11-30 2019-10-08 杭州鑫伟低碳技术研发有限公司 A kind of manufacturing method of dendrobium candidum suspended gel
CN108524383B (en) * 2017-03-02 2022-02-01 刘仲健 Orchid seed extract containing moisturizing or whitening components and additive product thereof
CN107006571A (en) * 2017-04-18 2017-08-04 安徽奥利休闲农业发展有限公司 A kind of method of utilization purple dendrobium slag biscuit
CN109223985A (en) * 2018-11-06 2019-01-18 胡爱娣 A kind of dendrobium candidum American Ginseng Ultramicro-powder microwave vacuum freeze drying means
CN110755345A (en) * 2019-10-30 2020-02-07 植物医生(广东)生物科技有限公司 Prebiotic composition and application thereof
CN116656758B (en) * 2023-06-26 2024-03-22 上海植纳生物科技有限公司 Dendrobium oligosaccharide and fresh dendrobium juice as well as preparation methods and applications thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1736167B1 (en) * 2005-06-20 2018-03-21 I.R.B. Istituto Di Ricerche Biotecnologiche S.r.l. Extracts obtained from cell line cultures from Syringa vulgaris IRB-SV25/B (DMS:16857), their preparation and use
EP2319914A1 (en) * 2009-11-09 2011-05-11 I.R.B. Istituto Di Ricerche Biotecnologiche S.r.l. Preparation and use of plant meristem cells with a high content of caffeic acid derivatives
EP2329836A1 (en) * 2009-12-03 2011-06-08 I.R.B. Istituto Di Ricerche Biotecnologiche S.r.l. Extracts obtained from hoodia gordonii cells lines, their preparation and use
EP2340808A1 (en) * 2009-12-21 2011-07-06 I.R.B. Istituto Di Ricerche Biotecnologiche S.r.l. Synergic combination of phenylpropanoids, such as verbascoside or teupolioside, and mesalamine

Also Published As

Publication number Publication date
FR2978161B1 (en) 2013-08-23
FR2978161A1 (en) 2013-01-25
FR2978160A1 (en) 2013-01-25

Similar Documents

Publication Publication Date Title
FR2978160B1 (en) PREPARATION AND USE OF MERISTEMATIC CELLS OF THE DENDROBIUM AND PHALAENOPSIS GENES WITH HIGH PHENYLPROPANOID CONTENT, WATER-SOLUBLE POLYSACCHARIDES AND EXTENSINS
CL2013000143A1 (en) Stable herbicidal granule containing an active herbicidal ingredient selected from inhibitors of the enzyme accase or als; method to control undesirable vegetation in an aquatic environment.
BR112014003708A2 (en) Methods for the production of 2,4-pentadienoate, butadiene, propylene, 1,3-butanediol and related alcohols
CA2841748C (en) Compositions and methods for modulating metabolic pathways
NZ713219A (en) Compositions and methods for epithelial stem cell expansion and culture
PH12018500371A1 (en) Clinical formulations
WO2012016188A3 (en) Methods and compositions for delivery of active agents
BR112013030456A2 (en) pharmaceutical composition comprising amide derivative inhibiting cancer cell growth and non-metallic salt lubricant
NZ717728A (en) Stable formulations of a hyaluronan-degrading enzyme
MX337454B (en) Aqueous composition comprising bromhexine.
SG178885A1 (en) Generation of ctl lines with specificity against multiple tumor antigens or multiple viruses
WO2013059582A3 (en) Small molecule inhibitors of histone deacteylases
WO2012103261A3 (en) Compositions and methods for succinate production
WO2013019857A3 (en) Method for improving the success rate of hematopoietic stem cell transplants
BR112013028544A2 (en) method for producing a heterologous acetyl-coa derivative compound
AR081870A1 (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES A PHARMACEUTICALLY ACCEPTABLE AMIDA DERIVATIVE OR SALT OF THE SAME
WO2013001372A3 (en) Methods and compositions for inhibition of activation of regulatory t cells
WO2012088225A3 (en) Method for identifcation and culture of multipotent mesenchymal stem cells with high proliferation potential
WO2012037043A8 (en) Treatment of autoimmune inflammation using mir-155
MX2013006838A (en) Effervescent compositions and uses thereof.
UA109894C2 (en) THE APPLICATION OF SUCCINDEGYDROGENASE INHIBITOR IN THE TREATMENT OF CULTURE TYPES OF PLANTS
NZ722687A (en) Use of succinate dehydrogenase inhibitors (sdhis) for controlling wood diseases in grape.
WO2013049856A8 (en) Renal stem cells isolated from kidney
CL2011002642A1 (en) Use of a composition formed by a glucocorticoid and a thiazolinedione that serves to induce adipogenic differentiation in stem cells.
LI Hao Expression analysis of the adenylate-isopentenyl transferase (A-IPT) genes in apple (Malus x Domestica Borkh.)

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13